Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients

Current Opinion in Infectious Diseases

Volumn 24, Issue 4, 2011, Pages 333-343

  Renaud, Christian ^a   Campbell, Angela P ^a,b,c,d  

^a Vaccine and Infectious Disease Division   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

bocavirus; coronaviruses; human metapneumovirus; influenza viruses; polyomaviruses; rhinoviruses; transplantation

Indexed keywords

2009 H1N1 INFLUENZA; ANTIVIRAL RESISTANCE; BOCAVIRUS; BOCAVIRUS INFECTION; CORONAVIRUS; CORONAVIRUS INFECTION; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LOWER RESPIRATORY TRACT INFECTION; METAPNEUMOVIRUS; METAPNEUMOVIRUS INFECTION; NONHUMAN; ORGAN TRANSPLANTATION; POLYOMA VIRUS; POLYOMAVIRUS INFECTION; REVIEW; RHINOVIRUS; RHINOVIRUS INFECTION;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ORGAN TRANSPLANTATION; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 79960225834     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3283480440     Document Type: Review

References (135)

1. Krunic N, Yager TD, Himsworth D, et al. xTAG RVP assay: analytical and clinical performance. J Clin Virol 2007; 40 (Suppl. 1):S39-S46. (Pubitemid 350298973)
2. Mahony JB. Nucleic acid amplification-based diagnosis of respiratory virus infections. Expert Rev Anti Infect Ther 2010; 8:1273-1292.
3. Kuypers J, Campbell AP, Cent A, et al. Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients. Transpl Infect Dis 2009; 11:298-303.
4. Balada-Llasat JM, Larue H, Kelly C, et al. Evaluation of commercial ResPlex II v2.0, MultiCode((R))-PLx, and xTAG((R)) respiratory viral panels for the diagnosis of respiratory viral infections in adults. J Clin Virol 2011; 50:42-45.
5. Martino R, Porras RP, Rabella N, et al. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant 2005; 11:781-796. (Pubitemid 41403760)
6. Martino R, Ramila E, Rabella N, et al. Respiratory virus infections in adults with hematologic malignancies: a prospective study. Clin Infect Dis 2003; 36:1-8. (Pubitemid 36099089)
7. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39:1300-1306. (Pubitemid 39458515)
8. Ljungman P, Ward KN, Crooks BN, et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001; 28:479-484. (Pubitemid 33069626)
9. Williams JV, Martino R, Rabella N, et al. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis 2005; 192:1061-1065. (Pubitemid 41266804)
10. Peck AJ, Englund JA, Kuypers J, et al. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection. Blood 2007; 110:1681-1688. (Pubitemid 47443987)
11. Chemaly RF, Ghosh S, Bodey GP, et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 2006; 85:278-287. (Pubitemid 44401460)
12. Machado CM, Boas LS, Mendes AV, et al. Low mortality rates related to respiratory virus infections after bone marrow transplantation. Bone Marrow Transplant 2003; 31:695-700. (Pubitemid 36553480)
13. Machado CM, Boas LS, Mendes AV, et al. Use of oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 2004; 34:111-114. (Pubitemid 39077100)
14. Schiffer JT, Kirby K, Sandmaier B, et al. Timing and severity of community acquired respiratory virus infections after myeloablative versus nonmyeloablative hematopoietic stem cell transplantation. Haematologica 2009; 94:1101-1108.
15. Nichols WG, Gooley T, Boeckh M. Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience. Biol Blood Marrow Transplant 2001; 7 (Suppl.):11S-15S. (Pubitemid 33734763)
16. Avetisyan G, Mattsson J, Sparrelid E, Ljungman P. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome. Transplantation 2009; 88:1222-1226.
17. Khanna N, Widmer AF, Decker M, et al. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis 2008; 46:402-412. (Pubitemid 351263523)
18. Nichols WG, Corey L, Gooley T, et al. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 2001; 98:573-578.
19. Oliveira R, Machado A, Tateno A, et al. Frequency of human metapneumovirus infection in hematopoietic SCT recipients during 3 consecutive years. Bone Marrow Transplant 2008; 42:265-269.
20. Kamboj M, Gerbin M, Huang CK, et al. Clinical characterization of human metapneumovirus infection among patients with cancer. J Infect 2008; 57:464-471.
21. Debur MC, Vidal LR, Stroparo E, et al. Human metapneumovirus infection in hematopoietic stem cell transplant recipients. Transpl Infect Dis 2009; 12:173-179.
22. Milano F, Campbell AP, Guthrie KA, et al. Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients. Blood 2010; 115:2088-2094.
23. Runde V, Ross S, Trenschel R, et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 2001; 28:51-57. (Pubitemid 32707617)
24. Muller A, Klinkenberg D, Vehreschild J, et al. Low prevalence of human metapneumovirus and human bocavirus in adult immunocompromised high risk patients suspected to suffer from Pneumocystis pneumonia. J Infect 2009; 58:227-231.
25. Garbino J, Soccal PM, Aubert JD, et al. Respiratory viruses in bronchoalveolar lavage: a hospital-based cohort study in adults. Thorax 2009; 64:399-404.
26. Peck Campbell A, Kuypers J, Nguyen P, et al. Human Bocavirus (BoV) detection in nasal washes of hematopoietic cell transplantation recipients [abstract]. In: Slide presentation at the 48th ICAAC/46th IDSA Annual Meeting, Washington, DC; October 28, 2008; abstract V-3777.
27. Mourez T, Bergeron A, Ribaud P, et al. Polyomaviruses KI and WU in immunocompromised patients with respiratory disease. Emerg Infect Dis 2009; 15:107-109.
28. Debiaggi M, Canducci F, Brerra R, et al. Molecular epidemiology of KI andWU polyomaviruses in infants with acute respiratory disease and in adult hematopoietic stem cell transplant recipients. J Med Virol 2010; 82:153-156.
29. Kuypers J, Peck Campbell A, Wright N, et al. Detection of WUV and KIV polyomaviruses in nasal wash specimens from hematopoietic cell transplant recipients [abstract]. In: Poster presentation at the 48th ICAAC/46th IDSA Annual Meeting, Washington, DC; 27 October 2008; abstract V-1642.
30. Boudreault AA, Xie H, Leisenring W, et al. Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus. Biol Blood Marrow Transplant 2010 [Epub ahead of print].
31. Gooskens J, Jonges M, Claas EC, et al. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis 2009; 199:1435-1441.
32. Gooskens J, Jonges M, Claas EC, et al. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus. JAMA 2009; 301:1042-1046.
33. Nichols WG, Erdman DD, Han A, et al. Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis. Biol Blood Marrow Transplant 2004; 10:58-64. (Pubitemid 38145740)
34. Erard V, Chien JW, Kim HW, et al. Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J Infect Dis 2006; 193:1619-1625. (Pubitemid 43839464)
35. Chien JW, Duncan S, Williams KM, Pavletic SZ. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation: an increasingly recognized manifestation of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16 (1 Suppl.):S106-S114.
36. Chien JW, Martin PJ, Gooley TA, et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003; 168:208-214. (Pubitemid 36920975)
37. Versluys AB, Rossen JW, van Ewijk B, et al. Strong association between respiratory viral infection early after hematopoietic stem cell transplantation and the development of life-threatening acute and chronic alloimmune lung syndromes. Biol Blood Marrow Transplant 2010; 16:782-791.
38. Au BK, Au MA, Chien JW. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplan 2010. [Epub ahead of print].
39. Lopez-Medrano F, Aguado JM, Lizasoain M, et al. Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study. Transplantation 2007; 84:851-856. (Pubitemid 351338945)
40. Gottlieb J, Schulz TF, Welte T, et al. Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study. Transplantation 2009; 87:1530-1537.
41. Hopkins P, McNeil K, Kermeen F, et al. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus. Am J Respir Crit Care Med 2008; 178:876-881.
42. Kumar D, Husain S, Chen MH, et al. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation 2010; 89: 1028-1033.
43. Liu M, Worley S, Arrigain S, et al. Respiratory viral infections within one year after pediatric lung transplant. Transpl Infect Dis 2009; 11:304-312.
44. Liu M, Mallory GB, Schecter MG, et al. Long-term impact of respiratory viral infection after pediatric lung transplantation. Pediatr Transplant 2010; 14:431-436.
45. Milstone AP, Brumble LM, Barnes J, et al. A single-season prospective study of respiratory viral infections in lung transplant recipients. Eur Respir J 2006; 28:131-137. (Pubitemid 44914270)
46. Soccal PM, Aubert JD, Bridevaux PO, et al. Upper and lower respiratory tract viral infections and acute graft rejection in lung transplant recipients. Clin Infect Dis 2010; 51:163-170.
47. Vilchez RA, McCurry K, Dauber J, et al. The epidemiology of parainfluenza virus infection in lung transplant recipients. Clin Infect Dis 2001; 33:2004-2008. (Pubitemid 33152394)
48. Weinberg A, Lyu DM, Li S, et al. Incidence and morbidity of human metapneumovirus and other community-acquired respiratory viruses in lung transplant recipients. Transpl Infect Dis 2010; 12:330-335.
49. Van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7:719-724. (Pubitemid 32588029)
50. Debiaggi M, Canducci F, Sampaolo M, et al. Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. J Infect Dis 2006; 194:474-478. (Pubitemid 44162658)
51. Debiaggi M, Canducci F, Terulla C, et al. Long-term study on symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. New Microbiol 2007; 30:255-258. (Pubitemid 47264884)
52. Englund JA, Boeckh M, Kuypers J, et al. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med 2006; 144:344-349. (Pubitemid 46768189)
53. Evashuk KM, Forgie SE, Gilmour S, et al. Respiratory failure associated with human metapneumovirus infection in an infant posthepatic transplant. Am J Transplant 2008; 8:1567-1569. (Pubitemid 351989502)
54. Richards A, Chuen JN, Taylor C, et al. Acute respiratory infection in a renal transplant recipient. Nephrol Dial Transplant 2005; 20:2848-2850. (Pubitemid 41672293)
55. Raza K, Ismailjee SB, Crespo M, et al. Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J Heart Lung Transplant 2007; 26:862-864. (Pubitemid 47199078)
56. Larcher C, Geltner C, Fischer H, et al. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology. J Heart Lung Transplant 2005; 24:1891-1901. (Pubitemid 41641867)
57. Dare R, Sanghavi S, Bullotta A, et al. Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis. J Clin Microbiol 2007; 45:548-552.
58. Allander T, Tammi MT, Eriksson M, et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 2005; 102:12891-12896. (Pubitemid 41279460)
59. Allander T, Jartti T, Gupta S, et al. Human bocavirus and acute wheezing in children. Clin Infect Dis 2007; 44:904-910. (Pubitemid 46452052)
60. Bastien N, Brandt K, Dust K, et al. Human Bocavirus infection, Canada. Emerg Infect Dis 2006; 12:848-850.
61. Martin ET, Taylor J, Kuypers J, et al. Detection of bocavirus in saliva of children with and without respiratory illness. J Clin Microbiol 2009; 47:4131-4132.
62. Schildgen O, Muller A, Allander T, et al. Human bocavirus: passenger or pathogen in acute respiratory tract infections? Clin Microbiol Rev 2008; 21:291-304. (Pubitemid 351555509)
63. Schenk T, Strahm B, Kontny U, et al. Disseminated bocavirus infection after stem cell transplant. Emerg Infect Dis 2007; 13:1425-1427. (Pubitemid 47510320)
64. Kainulainen L, Waris M, Soderlund-Venermo M, et al. Hepatitis and human bocavirus primary infection in a child with T-cell deficiency. J Clin Microbiol 2008; 46:4104-4105.
65. De Vries JJ, Bredius RG, van Rheenen PF, et al. Human bocavirus in an immunocompromised child presenting with severe diarrhea. J Clin Microbiol 2009; 47:1241-1243.
66. Schenk T, Maier B, Hufnagel M, et al. Persistence of human bocavirus DNA in immunocompromised children. Pediatr Infect Dis J 2011; 30:82-84.
67. Tozer SJ, Lambert SB, Whiley DM, et al. Detection of human bocavirus in respiratory, fecal, and blood samples by real-time PCR. J Med Virol 2009; 81:488-493.
68. Miyakis S, van Hal SJ, Barratt J, et al. Absence of human bocavirus in bronchoalveolar lavage fluid of lung transplant patients. J Clin Virol 2009; 44:179-180.
69. Costa C, Bergallo M, Cavallo R. Detection of human bocavirus in bronchoalveolar lavage from Italian adult patients. J Clin Virol 2009; 45:81-82.
70. Fouchier RA, Hartwig NG, Bestebroer TM, et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci USA 2004; 101:6212-6216. (Pubitemid 38520553)
71. Van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med 2004; 10:368-373. (Pubitemid 38508514)
72. Pene F, Merlat A, Vabret A, et al. Coronavirus 229E-related pneumonia in immunocompromised patients. Clin Infect Dis 2003; 37:929-932. (Pubitemid 37267207)
73. Oosterhof L, Christensen CB, Sengelov H. Fatal lower respiratory tract disease with human corona virus NL63 in an adult haematopoietic cell transplant recipient. Bone Marrow Transplant 2010; 45:1115-1116.
74. Folz RJ, Elkordy MA. Coronavirus pneumonia following autologous bone marrow transplantation for breast cancer. Chest 1999; 115:901-905. (Pubitemid 29129985)
75. Kuypers J, Martin ET, Heugel J, et al. Clinical disease in children associated with newly described coronavirus subtypes. Pediatrics 2007; 119:e70-e76. (Pubitemid 46397808)
76. Garbino J, Crespo S, Aubert JD, et al. A prospective hospital-based study of the clinical impact of nonsevere acute respiratory syndrome (non-SARS)-related human coronavirus infection. Clin Infect Dis 2006; 43:1009-1015. (Pubitemid 44631101)
77. Piralla A, Rovida F, Campanini G, et al. Clinical severity and molecular typing of human rhinovirus C strains during a fall outbreak affecting hospitalized patients. J Clin Virol 2009; 45:311-317.
78. Lau SK, Yip CC, Tsoi HW, et al. Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol 2007; 45:3655-3664. (Pubitemid 350156863)
79. Xiang Z, Gonzalez R, Xie Z, et al. Human rhinovirus C infections mirror those of human rhinovirus A in children with community-acquired pneumonia. J Clin Virol 2010; 49:94-99.
80. Ison MG, Hayden FG, Kaiser L, et al. Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia. Clin Infect Dis 2003; 36:1139-1143. (Pubitemid 36549634)
81. Parody R, Rabella N, Martino R, et al. Upper and lower respiratory tract infections by human enterovirus and rhinovirus in adult patients with hematological malignancies. Am J Hematol 2007; 82:807-811. (Pubitemid 350194510)
82. Gutman JA, Peck AJ, Kuypers J, Boeckh M. Rhinovirus as a cause of fatal lower respiratory tract infection in adult stem cell transplantation patients: a report of two cases. Bone Marrow Transplant 2007; 40:809-811. (Pubitemid 47521544)
83. Gerna G, Piralla A, Rovida F, et al. Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients. J Med Virol 2009; 81:1498-1507.
84. Kaiser L, Aubert JD, Pache JC, et al. Chronic rhinoviral infection in lung transplant recipients. Am J Respir Crit Care Med 2006; 174:1392-1399. (Pubitemid 44913042)
85. Allander T, Andreasson K, Gupta S, et al. Identification of a third human polyomavirus. J Virol 2007; 81:4130-4136. (Pubitemid 46586907)
86. Gaynor AM, Nissen MD, Whiley DM, et al. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 2007; 3:e64.
87. Dalianis T, Ramqvist T, Andreasson K, et al. KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus research. Semin Cancer Biol 2009; 19:270-275.
88. Astegiano S, Bergallo M, Solidoro P, et al. Prevalence and clinical impact of polyomaviruses KI and WU in lung transplant recipients. Transplant Proc 2010; 42:1275-1278.
89. Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362:2175-2184.
90. Belongia EA, Irving SA, Waring SC, et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008. (H3N2) infections. JAMA 2010; 304:1091-1098.
91. Shiley KT, Nadolski G, Mickus T, et al. Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza. Infect Control Hosp Epidemiol 2010; 31:676-682.
92. Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009; 9:493-504.
93. Choi S-M, Boudreault AA, Xie H, et al. Differences in clinical outcomes following 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood 2011 [Epub ahead of print].
94. Ditschkowski M, Elmaagacli AH, Beelen DW. H1N1 in allogeneic stem cell recipients: courses of infection and influence of vaccination on graft-versushost-disease (GVHD). Ann Hematol 2011; 90:117-118.
95. George B, Ferguson P, Kerridge I, et al. The clinical impact of infection with Swine flu (H1N1 09) strain of influenza virus in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2011; 17:147-153.
96. Protheroe RE, Kirkland KE, Pearce RM, et al. The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study. Bone Marrow Transplant 2011. [Epub ahead of print].
97. Rihani R, Hayajneh W, Sultan I, et al. Infections with the 2009 H1N1 influenza virus among hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant 2011 [Epub ahead of print].
98. Taplitz R, Espinosa-Aguilar L, Green J, et al. Novel H1N1 influenza in hematopoietic stem cell transplant recipients: two centers' experiences. Biol Blood Marrow Transplant 2011; 17:566-573.
99. Caselli D, Carraro F, Castagnola E, et al. Morbidity of pandemic H1N1 influenza in children with cancer. Pediatr Blood Cancer 2010; 55: 226-228.
100. Cost C, Brock E, Adams-Huet B, et al. 2009 pandemic influenza a (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients. Pediatr Blood Cancer 2011; 56:127-133.
101. Garland P, de Lavallade H, Sekine T, et al. Humoral and cellular immunity to primary H1N1 infection in patients with hematological malignancies and following stem cell transplantation. Biol Blood Marrow Transplant 2011; 17:632-639.
102. Lalayanni C, Sirigou A, Iskas M, et al. Outbreak of novel influenza A (H1N1) in an adult haematology department and haematopoietic cell transplantation unit: clinical presentation and outcome. J Infect 2010; 61:270-272.
103. Liu C, Schwartz BS, Vallabhaneni S, et al. Pandemic (H1N1) 2009 infection in patients with hematologic malignancy. Emerg Infect Dis 2010; 16:1910-1917.
104. Redelman-Sidi G, Sepkowitz KA, Huang CK, et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect 2010; 60:257-263.
105. Tramontana AR, George B, Hurt AC, et al. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis 2010; 16:1068-1075.
106. Vigil KJ, Adachi JA, Jiang Y, et al. Novel influenza A (2009/H1N1) infection in patients with hematological malignancies during the 2009 pandemic outbreak: early antiviral treatment improves survival [abstract]. In: Poster presentation at the 52nd ASH Annual Meeting and Exposition, Orlando, FL; 4-7 December 2010; Abstract I-1731.
107. Fox BD, Raviv Y, Rozengarten D, et al. Pandemic influenza (H1N1): impact on lung transplant recipients and candidates. J Heart Lung Transplant 2010; 29:1034-1038.
108. Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10:521-526.
109. Low CY, Kee T, Chan KP, et al. Pandemic (H1N1) 2009 infection in adult solid organ transplant recipients in Singapore. Transplantation 2010; 90: 1016-1021.
110. Ng BJ, Glanville AR, Snell G, et al. The impact of pandemic influenza A H1N1 2009. on Australian lung transplant recipients. Am J Transplant 2011; 11:568-574.
111. Ridao-Cano N, Sanchez-Fructuoso AI, Rodriguez-Moreno A, Barrientos A. H1N1 2009 influenza in kidney transplant patients. Transplantation 2010; 90:224-225.
112. Smud A, Nagel CB, Madsen E, et al. Pandemic influenza A/H1N1 virus infection in solid organ transplant recipients: a multicenter study. Transplantation 2010; 90:1458-1462.
113. Vazquez-Alvarez Mdel C, Medrano-Lopez C, Camino-Lopez M. H1N1 influenza vaccination and infection in pediatric heart transplants. J Heart Lung Transplant 2010; 29:1318.
114. Campbell AP, Jacob ST, Kuypers J, et al. Respiratory failure caused by 2009 novel influenza A/H1N1 in a hematopoietic stem-cell transplant recipient: Detection of extrapulmonary H1N1 RNA and use of intravenous peramivir. Ann Intern Med 2010; 152:619-620.
115. Renaud C, Pergam SA, Polyak C, et al. Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir. Transpl Infect Dis 2010; 12:513-517.
116. Hajjar LA, Mauad T, Galas FR, et al. Severe novel influenza A (H1N1) infection in cancer patients. Ann Oncol 2010; 21:2333-2341.
117. Dulek DE, Williams JV, Creech CB, et al. Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus. Clin Infect Dis 2010; 50:1493-1496.
118. Gaur AH, Bagga B, Barman S, et al. Intravenous zanamivir for oseltamivirresistant 2009. H1N1 influenza. N Engl J Med 2010; 362:88-89.
119. Rozovski U, Herishanu Y, Gipstein L, Naparstek E. Fatal H1N1 influenza infection in an allo-SCT recipient. Bone Marrow Transplant 2010; 45:1572-1573.
120. Speers DJ, Williams SH, Pinder M, et al. Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case. Med J Aust 2010; 192:166-168.
121. Garofano R, Rodriguez MA, Prados MC, et al. Cases of swine flu in kidney transplant recipients in our hospital. Transplant Proc 2010; 42:3141-3142.
122. Dohna-Schwake C, Schweiger B, Felderhoff-Muser U, et al. Severe H1N1 infection in a pediatric liver transplant recipient treated with intravenous zanamivir: efficiency and complications. Transplantation 2010; 90:223-224.
123. Anraku M, Husain S, Mazulli T, Pierre AF. Peri-operative novel 2009 H1N1 influenza virus infection successfully treated with oseltamivir and zanamivir in a lung transplant recipient. J Heart Lung Transplant 2011; 30:354.
124. Zapata R, Uribe M, Martinez W, et al. Severe novel H1N1 influenza A infection in the immediate postoperative period of a liver transplant patient. Liver Transpl 2010; 16:447-452.
125. Al Aklabi MM, Weinkauf JG, Humar A, Ghorpade N. Successful bilateral lung transplantation in a patient with end-stage lung disease and positive novel influenza virus (H1N1). J Heart Lung Transplant 2010; 29:898-899.
126. Weinstock DM, Gubareva LV, Zuccotti G. Prolonged shedding of multidrugresistant influenza A virus in an immunocompromised patient. N Engl J Med 2003; 348:867-868. (Pubitemid 36245772)
127. Carr S, Ilyushina NA, Franks J, et al. Oseltamivir-resistant influenza A and B viruses pre and postantiviral therapy in children and young adults with cancer. Pediatr Infect Dis J 2011; 30:284-288.
128. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients-Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:893-896.
129. Renaud C, Kuypers J, Corey L. Diagnostic accuracy of an allele-specific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A/H1N1 virus. J Clin Virol 2010; 49:21-25.
130. Deyde VM, Gubareva LV. Influenza genome analysis using pyrosequencing method: current applications for a moving target. Expert Rev Mol Diagn 2009; 9:493-509.
131. Inoue M, Barkham T, Leo YS, et al. Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 h. Emerg Infect Dis 2010; 16:1633-1636.
132. Harvala H, Gunson R, Simmonds P, et al. The emergence of oseltamivirresistant pandemic influenza A(H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009. Euro Surveill 2010; 15:1-3.
133. Renaud C, Boudreault AA, Kuypers J, et al. Clinical characteristics and viral kinetics of H275Y mutant pandemic H1N1 2009 influenza in immunocompromised patients. Emerg Infect Dis 2011; 17:653-660.
134. Le QM, Wertheim HF, Tran ND, et al. A community cluster of oseltamivirresistant cases of 2009 H1N1 influenza. N Engl J Med 2010; 362:86-87.
135. Chen LF, Dailey NJ, Rao AK, et al. Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients-North Carolina, 2009. J Infect Dis 2011; 203:838-846.